在疾病和治疗中准ubiquitination
Xiaojuan Yang1,2, Tian Lan1,3, Buzhe Zhang1
1Laboratory of Hepatic AI Translation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
Signal transduction and targeted therapy
|December 23, 2025
概括
乌比基因化是一种关键的蛋白质修饰,它调节细胞功能和恒常性. 它的失调导致疾病,使其成为新疗法 (如PROTACs) 的重要目标.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 乌比基因化是一种关键的翻译后修饰 (PTM),涉及乌比基因与蛋白质的附着.
- 这一过程对于细胞平衡至关重要,并调节各种生物功能.
- 无处不在的途径提供了对分子过程的多功能控制,但在疾病中可能受到失调.
研究的目的:
- 审查在无处不在化研究中的历史发展和关键里程碑.
- 探索无处不在在健康和疾病中的作用,包括机制和调节.
- 突出治疗策略和临床进展,以无处不在的途径为目标.
主要方法:
- 关于无处不在化研究的文献综述.
- 分析在各种病理条件中无处不在的作用.
- 检查新兴的治疗策略和临床试验.
主要成果:
- 化对细胞过程至关重要,其失调有助于癌症和神经退行等疾病.
- 该审查涵盖了ubiquitination的组件,机制,信号通路和监管功能.
- 新兴疗法,包括PROTACs和分子,显示出疾病治疗的前景.
结论:
- 了解无处不在对于阐明疾病发病因子至关重要.
- 针对无处不在的途径提供了新的治疗机会.
- 最近的临床研究和药物开发表明,在利用无处不在治疗疾病方面取得了重大进展.
相关概念视频
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.0K
3.0K
Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K


